Events

Innovative Health Initiative - Call Days - Call 9 & 10
JAN
Tue
07
JAN
Thu
16

This was 10 months ago

Location

Online

Programmes
Health

The Innovative Health Initiative is organising Call Days for Call 9 & 10 to provide interested stakeholders with all the necessary information needed to put together a proposal. The Call Days also offer the possiblity to identify potential partners.

Between 7 and 16 January, several webinars are scheduled to get acquainted with Call 9 and 10. Herewith an overview of the agenda:

Call 9 - single stage

  • 8 January 10:30 - 11:30 - Financial aspects of the proposal
  • 14 January 10:30 - 11:30 - General info on Call 9
  • 15 January 10:30 - 11:30 - Rules and procedures for single-stage calls


Call 10 - two stage

  • 7 January 10:30 - 11:30 - Session on topic: Digital label: one source of comprehensive information for medical technology products
  • 9 January 14:30 - 15:30 - Session on topic: Per-and Polcy-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector
  • 15 January 14:30 - 15:30 - Session on topic: Safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS)
  • 16 January 10:30 - 11:30 - Rules and procedures for two-stage calls


More information on the IHI website or register directly here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Sign Up

Only for stakeholders located in Flanders

Event calendar

 
45 upcoming events
Browse the complete event calendar

Agro-Food, Environment

Joint management of European Nature: The Natura 2000 Network and nature restoration as an opportunity

NOV
Thu
27
Organised by the Ministry of Natural Resources and Spatial Planning in collaboration with the Slovenian Business & Research Association, this event will gather decision-makers, policy experts, and practitioners committed to the future of European nature. The programme includes discussions on strategic priorities for the Natura 2000 network, in... read more 

Digital, Industry & Space

info session and brokerage event under cluster 4 of Horizon Europe

NOV
Thu
27
The UnILiON Brokerage Event focuses on cluster 4 of Horizon Europe (Digital, Industry and Space). The event seeks to foster collaboration and knowledge sharing among public and private sector stakeholders in preparation for upcoming Horizon Europe calls with 2026 deadlines. Participants may register as either attendees to listen to project pi... read more 

Horizon Europe

Webinar: Addressing IP impact and innovation in EU projects

NOV
Thu
27
The European IP Helpdesk is organising a webinar on different ways to define professional and systematic IP management in Horizon Europe projects. It requires an advanced level of expertise. Learning objectives: Impact and  innovation in HEU project proposals Exploitation of project results Business landscape in project proposa... read more 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article Check out the other testimonials 
Logo of VLAIO
Logo of FWO

NCP Flanders

Updates

Our Services

Legal mentions

Privacy Policy
Cookies

LinkedIn